GENEYE® Influenza Virus (FluA/B) ERA Assay is a molecular point-of-care testing system for rapid detection and differentiation of influenza A and B viruses. Utilizing enzymatic rapid amplification (ERA) technology, this assay enables on-site pathogen identification in clinical settings, reducing tim...
Manufactured by
Suzhou, Jiangsu, China
In 2007, GenDxbio was founded, which marked the company's initial stage. In 2017, GenDx Biotech was established and acquired GenDxbio in the same year. GenDx Biotech is committed to on-spot pathogens detection solutions with the molecular Point-of-Care Testing (POCT) technology platforms and the comprehensive instrument systems. Over the past two decades, ERA Technology (Enzymatic Rapid Amplification) and GENEYE ® systems developed by GenDx Biotech have been highly recongnized as a preferred solution for various pathogens identification in kinds of scenarios.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Deaou Gene Technology Co.,Ltd
China · 1 relevant product
Anbio Biotechnology Limited
Germany · 1 relevant product
Adaltis Srl
Italy · 1 relevant product
Futura System Group S.r.l.
Italy · 1 relevant product
CORIS BIOCONCEPT SRL
Belgium · 2 relevant products
Innovita (Tang Shan) Biological Technology Co.,Ltd.
China · 2 relevant products
Vircell S.L.
Spain · 1 relevant product
Diasorin
United States · 1 relevant product
GenBody Inc.
South Korea · 3 relevant products
Jiangsu Medomics Medical Technology Co.,Ltd.
China · 2 relevant products
61 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →7 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 96 closest product alternatives
Deaou Gene Technology Co.,Ltd · China
Molecular diagnostic assay for influenza virus detection with high sensitivity and specificity. Designed for rapid identification of influenza infections in clinical settings.
Anbio Biotechnology Limited · Germany
Rapid immunochromatographic assay for simultaneous detection of influenza A and B viral antigens. Provides point-of-care results for acute respiratory illness diagnosis.
Adaltis Srl · Italy
MicroELISA reagents designed for in-vitro diagnostic testing to detect viral infections, immune system diseases, and hormone responses. Compatible with automated microELISA analyzers including immunofluorescence assay preparation. Enables rapid and accurate clinical diagnosis across infectious disease and immunological applications.
Futura System Group S.r.l. · Italy
Rapid immunochromatographic assay for qualitative detection of Influenza A and B antigens using nasopharyngeal swabs. Enables differential identification of influenza strains including H1N1 subtype in symptomatic patients with results available within minutes.
CORIS BIOCONCEPT SRL · Belgium
An RT-LAMP (Reverse Transcription Loop-mediated isothermal Amplification) assay for the detection of Influenza A and B viruses using fluorometric detection.
Innovita (Tang Shan) Biological Technology Co.,Ltd. · China
A multiplexed rapid diagnostic test for the simultaneous detection and differentiation of Influenza A, Influenza B, and SARS-CoV-2 antigens. The test enables comprehensive respiratory pathogen screening in a single assay.
Vircell S.L. · Spain
Real-time PCR assay for screening and detection of Influenza A virus. The kit enables rapid identification of influenza A infections during seasonal epidemics and pandemic preparedness.
Diasorin · United States
CLIA-waived molecular diagnostic test delivering rapid infectious disease results in approximately 15 minutes. Combines detection of influenza A/B, respiratory syncytial virus, and COVID-19 in a single assay.
GenBody Inc. · South Korea
Rapid antigen test for qualitative detection of SARS-CoV-2 in respiratory specimens. The fluorescent immunochromatographic assay enables quick COVID-19 diagnosis with high sensitivity and specificity, suitable for point-of-care and laboratory settings.
Jiangsu Medomics Medical Technology Co.,Ltd. · China
Multiplex lateral flow assay for simultaneous detection of COVID-19 and influenza A and B antigens. Allows differentiation of respiratory pathogens in a single test.
Healgen Scientific LLC · United States
Rapid diagnostic test for simultaneous detection of influenza A/B and coronavirus antigens from nasopharyngeal or oropharyngeal specimens. CLIA-waived immunofluorescence assay enabling point-of-care results within minutes for respiratory pathogen screening and patient triage.
ZET MEDİKAL TEKSTİL DIŞ TİC.LTD.ŞTİ. · Türkiye
Lateral flow assay rapid diagnostic test for detection of influenza A and B viruses. Enables quick point-of-care diagnosis of seasonal influenza infections.
84 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products